Cuprina Holdings (Cayman) Limited is trading 5.5% down today at $4.13 as the stock undergoes a sharp pullback driven by profit-taking and technical mean reversion following its recent explosive rally.
- The stock is extending a correction after surging from below $0.30 to over $4.00 earlier this week, a move triggered by FDA 510(k) clearance for its MEDIFLY maggot-based wound-care product.
- Selling pressure has intensified as speculative momentum fades and investors lock in gains from the massive price spike.